MedPath

Synbiotic in Atopic Dermatitis in childre

Early Phase 1
Conditions
Atopic Dermatitis.
infantile (acute)(chronic)
L-20.8
Registration Number
IRCT201010204976N1
Lead Sponsor
vice chancellor for research, Mashhad University of medical sciences.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion:
Aged from 3 months to 6 years
Mild to severe Atopic dermatitis
Exclusion:
Prior exposure to probiotics
Were currently taking a course of antibiotics,
or had other major medical problems

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of Atopic Dermatitis. Timepoint: At the beginning of the study, 2 months after intervention. Method of measurement: SCORAD method.
Secondary Outcome Measures
NameTimeMethod
Cytokine profile(IL-4, INF- Gamma ). Timepoint: At the beginning of the study, 2 months after intervention. Method of measurement: ELISA on supernatant of Blood lymphocyte culture.
© Copyright 2025. All Rights Reserved by MedPath